scholarly journals Optimal Conversion Ratio of Oral Morphine to Transdermal Fentanyl Patches to the Cancer Pain

2009 ◽  
Vol 129 (3) ◽  
pp. 335-340 ◽  
Author(s):  
Junji OGAWA ◽  
Katsunori NAKAMURA ◽  
Keiko IIZUKA ◽  
Masayuki SEKIZUKA ◽  
Koujirou YAMAMOTO ◽  
...  
2004 ◽  
Vol 20 (9) ◽  
pp. 1419-1428 ◽  
Author(s):  
A. J. Clark ◽  
S. H. Ahmedzai ◽  
L. G. Allan ◽  
F. Camacho ◽  
G. L. A. Horbay ◽  
...  

2016 ◽  
Vol 34 (26_suppl) ◽  
pp. 196-196
Author(s):  
Yoshinobu Matsuda ◽  
Sachiko Okayama ◽  
Yoshito Yoshikawa ◽  
Yoshio Kobayashi

196 Background: In Japan, oral administration of methadone was approved for patients with cancer pain in March 2013. As methadone exhibits complex pharmacokinetics with individual differences and rare but serious adverse effects, methadone is only prescribed as a fourth-line drug by cancer pain specialists, who must start methadone according to the following table and must not increase methadone dose within 7 days. Aims: To assess the validity of the Japanese opioid conversion ratio. Methods: The clinical characteristics of 60 patients who were prescribed oral methadone between April 2013 and March 2016 were analyzed. Results: The switch from other opioids to methadone was initiated due to refractory pain in the stop-and-go switching. According to the table in Japan, the starting dose of methadone ranged from 15-45mg/day, depending on the previous opioid dose. Fifty cases (11 outpatients, 39 inpatients) were successfully switched to methadone; although 10 cases subsequently exhibited rapid progression of illness and failed due to oral difficulty during the course of dose titration. At the outset, the average oral morphine equivalent daily dose before methadone administration was 155mg (range, 40-660mg) and the starting methadone dose was 10 mg in 2 cases (extremely old age and multi-drug taking), 15 mg in 35 cases, 30 mg in 11 cases and 45 mg in 2 cases. Upon completion of the dose titration according to the Japanese definition, the methadone dose was the same as the starting dose in 21 cases, and was decreased or increased from the starting dose in 5 and 24 cases, respectively. Conclusions: TheJapanese opioid conversion ratio might be better corrected in the near future. For example, it is good to be able to start with 10mg or 20 mg because minute changes might lead the performance of low dose titration in some cases. It should be possible to increase the dose of methadone after 3 or 4 days from the later change based upon the pain severity. [Table: see text]


2002 ◽  
Vol 10 (4) ◽  
pp. 263-266 ◽  
Author(s):  
Dragana Radovanovic ◽  
Miroslava Pjevic ◽  
Zlatica Malbasa ◽  
Aleksandar Stosic

The management of pain is complex having to take into consideration patient specific characteristics. Drug therapy should be individualized and managed based on numerous factors. The opioid of first choice for the treatment of cancer pain is morphine, according to the European Association for Palliative Care (2000). Transdermally administered fentanyl is one alternative to oral morphine in the treatment of cancer pain. The transdermal systems are designed to deliver fentanyl at a constant rate for periods of 72 hours. Patches with a delivery rate of 25, 50, 75 and 100 ?g/h are available. Treatment with transdermal fentanyl is safe and acceptable to many cancer patients. Significantly more patients expressed a preference for transdermal fentanyl than for sustained release oral morphine. The global score of adverse effects was significantly lower in patients receiving transdermal fentanyl than in those receiving sustained release oral morphine. The transdermal fentanyl patch is as effective as oral opioids in relieving cancer related pain, with a safety and side effect profile equal to or better than that of oral opioids.


2011 ◽  
Vol 27 (8) ◽  
pp. 664-667 ◽  
Author(s):  
Yuko Kanbayashi ◽  
Toyoshi Hosokawa ◽  
Kousuke Okamoto ◽  
Sawako Fujimoto ◽  
Hideyuki Konishi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document